Blog

Tom Powles and Giorgio Bogani Discuss the Recently Published Study on Advanced or Recurrent Endometrical Cancer

Photo collage of Tom Powles and Giorgio Bogani taken from their LinkedIn

Jun 15, 2024, 07:36

Tom Powles and Giorgio Bogani Discuss the Recently Published Study on Advanced or Recurrent Endometrical Cancer

The European Society for Medical Oncology (ESMO) posted on LinkedIn:

“Latest podcast Annals of Oncology Editor-in-Chief Tom Powles talks to Giorgio Bogani. They discuss the recently published study considering recent phase III trials that investigated the role of Immunotherapy in the first-line setting for advanced or recurrent Endometrical Cancer.”

Read further.
Source: The European Society for Medical Oncology (ESMO)/LinkedIn

advanced cancer Annals of Oncology cancer Cancer research cancer studies Endometrial cancer ESMO first-line treatment Giorgio Bogani immunotherapy OncoDaily Oncology oncology podcast phase III trials recurrent cancer Tom Powles

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer